/ /

Cheryl Guttman Krader
WFG offers therapeutic option for postRK eyes
Wavefront-guided ablation using either LASIK or PRK is a safe and effective therapeutic option for improving visual problems in patients with a history of radial keratotomy, according to Mounir A. Khalifa, MD.
FDA approves tafluprost
On Feb. 13, Merck announced that it received approval from the FDA to market its one-of-a-kind, preservative-free, prostaglandin analog, tafluprost ophthalmic solution 0.0015%, for lowering IOP in patients with open-angle glaucoma or ocular hypertension.
'High-definition ocular coherence tomography update adds age-related macular degeneration, glaucoma tools
New software (version 6.0) introduced for a proprietary high-definition ocular coherence tomography platform provides researchers and clinicians an expanded set of diagnostic tools to use in the evaluation and management of patients with AMD and glaucoma.
Software tracks geographic atrophy
Ophthalmologists using a proprietary confocal scanning laser ophthalmoscope with a fundus autofluorescence module can now quantify and track progression of geographic atrophy over time, thanks to the release of new software.
Aflibercept a viable regimen
Results from an integrated analysis of data from 12 months of follow-up in the two similarly designed prospective, randomized studies comparing aflibercept and ranibizumab indicate that intravitreal injection of aflibercept every 2 months is safe, predictably effective therapy for neovascular age-related macular degeneration and comparable to monthly ranibizumab 0.5 mg.
Case study: Dysphotopsias
Severe halos/glare was the issue most feared most by surgeons implanting diffractive multifocal IOLs, according to a survey.
WFO, WFG myopic PRK clinical outcomes compared
Results from a prospective randomized eye-to-eye study comparing wavefront-optimized (WFO) and wavefront-guided (WFG) myopic PRK show the WFO technique affords faster visual recovery, but ultimately, quantity and quality of vision appear to be better after WFG PRK, said co-investigators Anthony C. Liu, MD, and Edward Manche, MD.
Results favor primary use of artificial cornea
Results from a retrospective study show that the Boston Type I keratoprosthesis (Boston KPro, Massachusetts Eye and Ear Infirmary) is a safe and effective primary method for visual rehabilitation in eyes with corneal blindness not related to autoimmune conditions, said Kathryn A. Colby, MD, PhD.
FDA gives nod for aspheric lens
Rayner Intraocular Lenses Ltd. Received approval from the FDA in December 2011 to market the C-flex Aspheric 970C IOL in the United States.
Education key for glaucoma care
Findings from various patient surveys of satisfaction with medical care show that many of the commonly cited complaints can be mitigated by appropriate patient education.


View Results